Privi Speciality Shareholders Approve Merger of Two Subsidiaries
Privi Speciality Chemicals Ltd 路 Court Convened Meeting 路 27 Oct 2026, 7:39 pm
Privi Speciality Shareholders Approve Merger of Two Subsidiaries Privi Speciality Chemicals Limited announced that its equity shareholders approved the Scheme of Amalgamation of Privi Fine Sciences Private Limited and Privi Biotechnologies Private Limited with the company via a special resolution with requisite majority. The decision was formalized at an NCLT-convened meeting held on 27th Oct'26 pursuant to the NCLT Mumbai Bench order dated 7th Sep'26. Final e-voting results will be declared upon receipt of the scrutinizer's report and submitted to stock exchanges.
Original exchange filing (PDF)
More announcements from Privi Speciality Chemicals Ltd
- Announcement under Reg 30 - Transcript of Q2 Earnings Call held on October 30, 2026. 路 03 Nov 2026
- Outcome of Earnings Call held on 30.10.2026 @ 04:00 pm - Audio Link 路 31 Oct 2026
- Investor Presentation - Financial & Operational Review for Quarter and half year ended September 30,2026. 路 30 Oct 2026
- Outcome of Board Meeting held on October 29.10.2026 to consider and approve Financial Results of Q2 FY27, declaration of Interim Dividned and Proposed investment in Solar Power Project. 路 29 Oct 2026
- Outcome of Board Meeti ng - Approving Record Date for the purpose of Interim Dividend 路 29 Oct 2026
- Outcome of Board Meeting - Approval of 1st Interim Dividned FY 2026-27 路 29 Oct 2026
- Outcome of Board Meeting - Financial Results for quarter and half year ended September 30, 2026 路 29 Oct 2026
- Privi Speciality Chemicals Limited has submitted to the Exchange, the outcome of the Board Meeting held on October 29,2026. 路 29 Oct 2026
